tiprankstipranks
Helix Biopharma Corp. (TSE:HBP)
:HBP
Canadian Market
Holding TSE:HBP?
Track your performance easily

Helix BioPharma (HBP) Financial Statements

25 Followers

Helix BioPharma Financial Overview

Helix BioPharma's market cap is currently ―. The company's EPS TTM is C$-0.201; its P/E ratio is ―; Helix BioPharma is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 24Jul 24Apr 24Jan 24Oct 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.33M-$ -1.83M$ -880.00K$ -1.25M
EBITDA$ -1.33M-$ -1.82M$ -877.00K$ -1.25M
Net Income Common Stockholders$ -1.34M-$ -1.83M$ -902.00K$ -1.25M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 228.00K$ 1.08M$ 710.00K$ 120.00K$ 1.64M
Total Assets$ 414.00K$ 1.49M$ 1.15M$ 343.00K$ 1.90M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 1.78M$ 1.58M$ 1.50M$ 603.00K$ 1.27M
Stockholders Equity$ -1.36M$ -90.00K$ -851.00K$ -259.00K$ 622.00K
Cash Flow-
Free Cash Flow$ -853.00K$ -749.00K---
Operating Cash Flow$ -861.00K$ -747.00K$ -1.13M$ -1.49M$ -1.85M
Investing Cash Flow$ 8.00K$ -2.00K--$ -12.00K
Financing Cash Flow-$ 1.10M$ 1.72M$ 1.00K$ 2.69M
Currency in USD

Helix BioPharma Earnings and Revenue History

Helix BioPharma Debt to Assets

Helix BioPharma Cash Flow

Helix BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis